Elon Musk Sparks Legal Showdown With $1 Million Voter Payouts In Wisconsin, Defying Court Battle - Tesla ( NASDAQ:TSLA )
Billionaire and Tesla Inc. TSLA CEO Elon Musk has distributed $1 million checks to Wisconsin voters after the state supreme court declined to intervene in a legal challenge to the giveaway.
Trump's 'Liberation Day' Tariffs Could Fuel Inflation After $16 Trillion Fiscal Surge, Lawrence McDonald Warns - Invesco QQQ Trust, Series 1 ( NASDAQ:QQQ ) , SPDR Dow Jones Industrial Average ETF ( ARCA:DIA )
Lawrence McDonald, founder of Bear Traps Report, warned on Sunday that President Donald Trump's planned tariffs could have a more significant inflationary impact during his second term compared to his first administration.
PVH Gears Up For Q4 Print; Here Are The Recent Forecast Changes From Wall Street's Most Accurate Analysts - PVH ( NYSE:PVH )
PVH Corp. PVH will release its fourth-quarter financial results after the closing bell on Monday, March 31. Analysts expect the company to report quarterly earnings at $3.22 per share, down from $3.72 per share in the year-ago period.
Elon Musk Dismisses Dogecoin Use By Government, Clears The Air On DOGE Department: 'Two Very Different Things'
Influential tech entrepreneur Elon Musk categorically ruled out the idea of the U.S. government using Dogecoin DOGE/USD on Sunday, even though his initiative, the Department of Government Efficiency, makes a playful reference to the meme-based cryptocurrency.
NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025
Conference call and webcast scheduled for Thursday, April 3, 2025, at 8:00 am EDT / 2:00 pm CEST Conference call and webcast scheduled for Thursday, April 3, 2025, at 8:00 am EDT / 2:00 pm CEST ...
NANOBIOTIX to Announce Fourth Quarter and Full Year 2024 Operational and Financial Update on April 2, 2025 - Nanobiotix ( NASDAQ:NBTX )
PARIS and CAMBRIDGE, Mass., March 31, 2025 ( GLOBE NEWSWIRE ) -- NANOBIOTIX ( Euronext: NANO -- NASDAQ:NBTX - the ''Company'' ) , a late-clinical stage biotechnology company pioneering nanoparticle-based approaches to expand treatment possibilities for patients with cancer and other major ...